人工電子耳市場:按患者類型、最終用戶和地區進行分析和預測(2024 至 2034 年)
市場調查報告書
商品編碼
1667209

人工電子耳市場:按患者類型、最終用戶和地區進行分析和預測(2024 至 2034 年)

Cochlear Implants Market - A Global and Regional Analysis: Focus on Patient Type, End User, and Region - Analysis and Forecast, 2024-2034

出版日期: | 出版商: BIS Research | 英文 70 Pages | 商品交期: 1-5個工作天內

價格

全球人工電子耳市場規模預計將從 2023 年的 24.244 億美元成長到 2034 年的 66.399 億美元,預測期內的複合年成長率為 9.02%。

近年來,人工電子耳市場呈現強勁成長勢頭,預計仍將繼續擴大,儘管成長速度可能因情況而異。人工電子耳是一種電子醫療設備,旨在為無法從傳統助聽器中受益的中度至重度聽力損失患者提供聲音感知。這些植入繞過內耳(耳蝸)受損區域並直接刺激聽覺神經,使用戶能夠感知聲音並提高對語音的理解。

主要市場統計數據
預測期 2024-2034
2024 年評估 28.2億美元
2034 年預測 66.399 億美元
複合年成長率 9.02%

受聽力恢復技術的進步和感音性聽障盛行率不斷上升的推動,全球人工電子耳市場正在經歷顯著成長。根據世界衛生組織(WHO)發布的資料,全球有超過4.3億人有聽力損失,預計到2050年這數字將達到7億。此外,人工電子耳技術的進步,包括更有效、更方便用戶使用的基於人工智慧的語音處理、無線連接和 MRI 相容植入,預計將顯著改善患者的治療效果。全球各國政府和醫療保健組織也透過優惠的報銷政策和資助計畫支持市場,提高兒科和成人患者的治療可及性。

根據患者類型,成人群體佔據市場主導地位:

根據患者類型,成人患者將在 2023 年佔據最大佔有率,預計到 2034 年將達到 42.827 億美元,預測期內的複合年成長率為 8.55%。與老齡化相關的聽力損失的盛行率正在增加,人工電子耳作為治療方法中度至重度聽力損失的有效方法越來越受到廣泛認可。隨著全球老齡人口的成長,成人對人工人工電子耳的需求大幅成長,尤其是在北美、歐洲等已開發地區。此外,隨著植入設計、手術技術和植入後復原的不斷創新,成人市場預計將在未來幾年內在人工電子耳市場保持主導地位。

根據最終用戶,醫院部門佔據市場主導地位:

根據最終用戶,醫院部門預計將在 2023 年佔據最大佔有率,預計到 2034 年將達到 41.831 億美元,預測期內的複合年成長率為 8.71%。主導市場的關鍵因素是成功移植所需的先進手術基礎設施、耳鼻喉設備、熟練的醫療專業人員和術後復健服務。該醫院是兒科和成人患者的主要照護端,提供全面的診斷評估、手術植入和長期聽力支持。由耳鼻喉科專家、聽力學家、語言治療師和復健專家組成的多學科團隊可確保最佳的患者治療效果,進一步有利於醫院內的人工電子耳植入手術。

人工電子耳市場細分

細分一:按患者類型

  • 成人
  • 孩子們

細分 2:按最終用戶

  • 醫院
  • 耳鼻喉科診所
  • 其他

細分 3:按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

本報告調查了全球人工電子耳市場,並總結了主要趨勢、影響市場的因素分析、法律制度、市場規模的趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

執行摘要

範圍和定義

第1章市場:產業展望

  • 趨勢:當前和未來的影響評估
  • 供應鏈分析
  • 監管狀態
  • 市場動態概覽
    • 影響分析
    • 市場促進因素
    • 市場限制
    • 市場機會

2. 全球人工電子耳市場依患者類型分類

  • 成人
  • 孩子們

3. 全球人工電子耳市場(以最終用戶分類)

  • 醫院
  • 耳鼻喉科診所
  • 其他

第4章 區域

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第5章市場:競爭基準化分析與公司概況

  • 主要進展
  • 公司簡介
    • iotaMotion, Inc.
    • Envoy Medical
    • Amplifon, (GAES)
    • Cochlear Ltd.
    • Sonova Holdings AG
    • MED-EL Medical Electronics
    • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)

第6章調查方法

Product Code: BHM2572SA

Introduction of Cochlear Implants

The global cochlear implants market, initially valued at $2,424.4 million in 2023, is set to witness substantial growth, projected to surge to $6,639.9 million by 2034, marking a remarkable compound annual growth rate (CAGR) of 9.02% over the period from 2024 to 2034. The cochlear implants market has shown robust growth in recent years and is poised to continue expanding, though the pace may vary under different conditions. Cochlear implants are electronic medical devices designed to provide sound perception to individuals with severe-to-profound hearing loss who do not benefit from conventional hearing aids. These implants directly stimulate the auditory nerve, bypassing damaged parts of the inner ear (cochlea), enabling users to perceive sound and improve speech comprehension.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$2,800.2 Million
2034 Forecast$6,639.9 Million
CAGR9.02%

The global cochlear implants market has been experiencing significant growth, fueled by advancements in hearing restoration technologies and the increasing prevalence of sensorineural hearing loss. According to the data published by the World Health Organization (WHO), over 430 million people worldwide suffer from disabling hearing loss, with this number expected to reach 700 million by 2050. Additionally, advancements in cochlear implant technology, such as AI-based sound processing, wireless connectivity, and MRI-compatible implants, have significantly improved patient outcomes, making these devices more effective and user-friendly. Governments and healthcare organizations worldwide are also supporting the market through favorable reimbursement policies and funding initiatives, increasing accessibility for both pediatric and adult patients.

Industrial Impact

The cochlear implants market has significantly influenced the healthcare landscape, driven by key players such as Cochlear Limited., Sonova Holdings AG, Amplifon, (GAES), and others. These companies have been at the forefront, providing cutting-edge products for cochlear implants.

Moreover, the market has been further shaped by strategic collaborations, mergers, and R&D investments, which enable companies to expand their global presence and introduce innovative solutions. With the increasing focus on understanding tissue architecture and disease mechanisms, the competitive landscape of the cochlear implants market is dynamic, with innovation and customer-centric approaches driving differentiation and growth.

Market Segmentation for Cochlear Implants Market:

Segmentation 1: by Patient Type

  • Adult
  • Pediatric

Adult Segment to Dominate the Cochlear Implants Market (by Patient Type)

Based on patient type, the global cochlear implants market was led by the adult segment, which accounted for the largest share in 2023 and is expected to reach $4,282.7 million by 2034, registering a CAGR of 8.55% during the forecast period 2024-2034. The rising prevalence of age-related hearing loss and increasing awareness of cochlear implantation as an effective treatment for severe-to-profound hearing impairment. With a growing global geriatric population, particularly in developed regions such as North America and Europe, the demand for cochlear implants among adults is increasing significantly. Additionally, with continued innovation in implant design, surgical techniques, and post-implantation rehabilitation, the adult segment is expected to maintain its dominance in the cochlear implant market in the coming years.

Segmentation 2: by End User

  • Hospitals
  • ENT Clinics
  • Others

Hospitals Segment to Dominate the Cochlear Implants Market (by End User)

Based on end user, hospitals accounted for the largest share in 2023 and are expected to reach $4,183.1 million by 2034, registering a CAGR of 8.71% during the forecast period 2024-2034. A key factor contributing to the market's dominance is the availability of advanced surgical infrastructure, ENT devices, skilled healthcare professionals, and post-operative rehabilitation services required for successful implantation. Hospitals serve as the primary point of care for both pediatric and adult patients, offering comprehensive diagnostic assessments, surgical implantation, and long-term audiological support. The presence of multidisciplinary teams, including ENT specialists, audiologists, speech therapists, and rehabilitation experts, ensures optimal patient outcomes, further driving preference for hospital-based cochlear implant procedures.

Segmentation 3: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

In 2023, North America region dominated the global cochlear implants market; however, the Asia-Pacific region is expected to register the highest CAGR of 10.53% during the forecast period 2024-2034. high healthcare expenditure, advanced medical infrastructure, and strong government support for hearing loss treatment are a few factors driving the growth of the region. The increasing awareness about hearing restoration solutions, along with the rising adoption of bilateral cochlear implantation, further supports market growth. Moreover, an aging population and the rising prevalence of age-related hearing loss have fueled demand among older adults seeking cochlear implants to improve their quality of life.

Recent Developments in the Cochlear Implants Market

  • In May 2024, Cochlear Limited completed the acquisition of Oticon Medical's cochlear implant business from Demant, integrating approximately 20,000 Oticon Medical cochlear implant customers into its operations. This strategic move aims to provide continued support and transition these customers to Cochlear's technology platform over time.
  • In March 2023, MED-EL Medical Electronics introduced direct streaming for their cochlear implant patients. This feature, available in their new MED-EL cochlear implant systems, allows users to stream audio directly from compatible devices (such as smartphones) to their implants, improving sound quality and convenience. This innovation enhances accessibility and user experience for individuals with hearing loss.
  • In November 2024, Cochlear Limited launched the Nucleus 8 Sound Processor, featuring enhanced connectivity for direct streaming from Apple and Android devices and improved hearing in noisy environments. This innovation aims to provide clearer sound and greater convenience for individuals with hearing loss.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Prevalence of Hearing Loss: The global prevalence of hearing loss is increasing at an alarming rate, driven by factors such as aging populations, excessive noise exposure, genetic predisposition, and untreated ear infections. According to the World Health Organization (WHO), over 1.5 million people worldwide currently experience some degree of hearing impairment, with this number expected to rise due to demographic and environmental factors. Additionally, increased awareness and early diagnosis are leading to a higher adoption of hearing aids and cochlear implants, addressing the needs of individuals with severe to profound hearing loss.

Market Challenges:

High Cost of Devices and Surgery: Despite the benefits of cochlear implants, their high cost remains a significant barrier limiting market penetration, particularly in low- and middle-income countries. A single cochlear implant procedure (including the device, surgery, and rehabilitation therapy) can cost $50,000 to $100,000 in the U.S., and prices are similarly steep elsewhere. Without insurance or subsidies, this expense is prohibitive for most patients. In developing regions, the lack of affordability is a primary reason that so few people who need implants receive them. Globally, it's estimated that only about 5-10% of candidates who could benefit from a cochlear implant have one, largely due to cost and access issues. The result is a substantial unmet medical need, where millions continue to live with severe hearing loss because the up-front price of treatment is out of reach.

Market Opportunities:

Increasing Adoption in Emerging Markets: Emerging markets present a significant growth opportunity for the cochlear implants market due to improving healthcare infrastructure, rising awareness of hearing loss treatments, and increasing disposable income. Countries in Asia-Pacific, Latin America, and Africa are witnessing a surge in demand for cochlear implants as governments and healthcare organizations work toward expanding access to advanced medical technologies. Additionally, initiatives like subsidized healthcare programs, insurance coverage expansion, and partnerships with global medical device companies are making cochlear implants more affordable and accessible.

How can this report add value to an organization?

Product/Innovation Strategy: The global cochlear implants market has been extensively segmented based on various categories, such as patient type, end user, and region.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments in the market.

Competitive Strategy: The global cochlear implants market has numerous established players with product portfolios. Key players in the global cochlear implants market analyzed and profiled involve established players offering products for cochlear implants.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2021-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of the cochlear implants market.
  • The market size was estimated and validated using both bottom-up and top-down analyses. The market size for each type, patient type, and end user was estimated for the bottom-up approach. These were further added to cumulate the market size of the global cochlear implants market.
  • The top-down analysis was conducted to arrive at the market contributions of various segments as defined in the scope.
  • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year.
  • The market has been mapped based on available cochlear implants. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in cochlear implants, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players of the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Cochlear Limited.
  • Sonova Holding AG.
  • Zhejiang Nurotron Biotechnology Co., Ltd. (Nurotron)
  • MED-EL Medical Electronics

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Miniaturization of Sensors and Components in Hearing Implants
  • 1.2 Supply Chain Analysis
  • 1.3 Regulatory Landscape
    • 1.3.1 U.S.
    • 1.3.2 Europe
    • 1.3.3 Asia-Pacific
    • 1.3.4 Rest-of-the-World
  • 1.4 Market Dynamics Overview
    • 1.4.1 Impact Analysis
    • 1.4.2 Market Drivers
      • 1.4.2.1 Rising Prevalence of Hearing Loss
      • 1.4.2.2 Technological Advancements in Cochlear Implants
      • 1.4.2.3 Government Health Initiatives and Favorable Reimbursement
    • 1.4.3 Market Restraints
      • 1.4.3.1 High Cost of Devices and Surgery
      • 1.4.3.2 Low Awareness Related to Cochlear Implants
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Increasing Adoption in Emerging Markets

2 Global Cochlear Implants Market, by Patient Type

  • 2.1 Adults
  • 2.2 Pediatric

3 Global Cochlear Implants Market, by End User

  • 3.1 Hospitals
  • 3.2 ENT Clinics
  • 3.3 Others

4 Regions

  • 4.1 North America
    • 4.1.1 Regional Overview
    • 4.1.2 Driving Factors for Market Growth
    • 4.1.3 Factors Challenging the Market
    • 4.1.4 Market Sizing and Forecast
      • 4.1.4.1 U.S.
      • 4.1.4.2 Canada
  • 4.2 Europe
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Market Sizing and Forecast
      • 4.2.4.1 Germany
      • 4.2.4.2 U.K.
      • 4.2.4.3 France
      • 4.2.4.4 Italy
      • 4.2.4.5 Spain
      • 4.2.4.6 Rest-of-Europe
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Market Sizing and Forecast
      • 4.3.4.1 Japan
      • 4.3.4.2 China
      • 4.3.4.3 India
      • 4.3.4.4 Rest-of-Asia-Pacific
  • 4.4 Latin America
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Market Sizing and Forecast
      • 4.4.4.1 Brazil
      • 4.4.4.2 Mexico
      • 4.4.4.3 Rest-of-Latin America
  • 4.5 Middle East and Africa
    • 4.5.1 Regional Overview
    • 4.5.2 Market Sizing and Forecast

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Key Developments
    • 5.1.1 Key Strategies and Development
  • 5.2 Company Profiles
    • 5.2.1 iotaMotion, Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Analyst View
    • 5.2.2 Envoy Medical
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Analyst View
    • 5.2.3 Amplifon, (GAES)
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Analyst View
    • 5.2.4 Cochlear Ltd.
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Analyst View
    • 5.2.5 Sonova Holdings AG
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Analyst View
    • 5.2.6 MED-EL Medical Electronics
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Analyst View
    • 5.2.7 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Cochlear Implants Market (by Patient Type), $Million, 2023 and 2034
  • Figure 2: Global Cochlear Implants Market (by End User), $Million, 2023 and 2034
  • Figure 3: Global Cochlear Implant Market (by Region), $Million, 2023, 2027, and 2034
  • Figure 4: Key Events to Keep Track of in the Global Cochlear Implants Market
  • Figure 5: Supply Chain Analysis: Global Cochlear Implants Market
  • Figure 6: Impact Analysis of Cochlear Implants Market Navigating Factors, 2024-2034
  • Figure 7: North America Cochlear Implants Market, $Million, 2023-2034
  • Figure 8: U.S. Cochlear Implants Market, $Million, 2023-2034
  • Figure 9: Canada Cochlear Implants Market, $Million, 2023-2034
  • Figure 10: Europe Cochlear Implants Market, $Million, 2023-2034
  • Figure 11: Germany Cochlear Implants Market, $Million, 2023-2034
  • Figure 12: U.K. Cochlear Implants Market, $Million, 2023-2034
  • Figure 13: France Cochlear Implants Market, $Million, 2023-2034
  • Figure 14: Italy Cochlear Implant Market, $Million, 2023-2034
  • Figure 15: Spain Cochlear Implants Market, $Million, 2023-2034
  • Figure 16: Rest-of-Europe Cochlear Implants Market, $Million, 2023-2034
  • Figure 17: Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
  • Figure 18: Japan Cochlear Implants Market, $Million, 2023-2034
  • Figure 19: China Cochlear Implants Market, $Million, 2023-2034
  • Figure 20: India Cochlear Implants Market, $Million, 2023-2034
  • Figure 21: Rest-of-Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
  • Figure 22: Latin America Cochlear Implants Market, $Million, 2023-2034
  • Figure 23: Brazil Cochlear Implants Market, $Million, 2023-2034
  • Figure 24: Mexico Cochlear Implants Market, $Million, 2023-2034
  • Figure 25: Rest-of-Latin America Cochlear Implants Market, $Million, 2023-2034
  • Figure 26: Middle East and Africa Cochlear Implants Market, $Million, 2023-2034
  • Figure 27: Strategic Initiatives, January 2020-January 2025
  • Figure 28: Data Triangulation
  • Figure 29: Top-Down and Bottom-Up Approach
  • Figure 30: Assumptions and Limitations

List of Tables

  • Table 1: Key Trends, Global Cochlear Implants Market
  • Table 2: Evolution of Component Size in Hearing Implants
  • Table 3: Global Prevalence of Hearing Loss, 2019-2021
  • Table 4: Global Cochlear Implants Market (by Patient Type), $Million, 2023-2034
  • Table 5: Global Cochlear Implants Market (by End User), $Million, 2023-2034
  • Table 6: Global Cochlear Implants Market (by Region), $Million, 2023-2034
  • Table 7: Recent Developments by Companies in the Global Cochlear Implants Market, 2023 and 2024